These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7693368)

  • 21. Calcitonin gene-related peptide promotes differentiation, but not survival, of rat mesencephalic dopaminergic neurons in vitro.
    Bürvenich S; Unsicker K; Krieglstein K
    Neuroscience; 1998 Oct; 86(4):1165-72. PubMed ID: 9697123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The nature of the trophic action of brain-derived neurotrophic factor, des(1-3)-insulin-like growth factor-1, and basic fibroblast growth factor on mesencephalic dopaminergic neurons developing in culture.
    Beck KD; Knüsel B; Hefti F
    Neuroscience; 1993 Feb; 52(4):855-66. PubMed ID: 8095710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence for a novel neurotrophic factor for dopaminergic neurons secreted from mesencephalic glial cell lines.
    Engele J; Rieck H; Choi-Lundberg D; Bohn MC
    J Neurosci Res; 1996 Mar; 43(5):576-86. PubMed ID: 8833092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potent cocaine analogs inhibit [3H]dopamine uptake in rat mesencephalic cells in primary cultures: pharmacological selectivity of embryonic cocaine sites.
    Brouard A; Pelaprat D; Boja JW; Carroll FI; Vial M; Kuhar MJ; Rostene W
    Brain Res Dev Brain Res; 1993 Sep; 75(1):13-7. PubMed ID: 8222207
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuronal-enriched cultures from embryonic rat ventral mesencephalon for pharmacological studies of dopamine neurons.
    Pardo B; Paíno CL; Casarejos MJ; Mena MA
    Brain Res Brain Res Protoc; 1997 May; 1(2):127-32. PubMed ID: 9385075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polychlorinated biphenyl-induced neurotoxicity in organotypic cocultures of developing rat ventral mesencephalon and striatum.
    Lyng GD; Snyder-Keller A; Seegal RF
    Toxicol Sci; 2007 May; 97(1):128-39. PubMed ID: 17324953
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ascorbic acid in mesencephalic cultures: effects on dopaminergic neuron development.
    Kalir HH; Mytilineou C
    J Neurochem; 1991 Aug; 57(2):458-64. PubMed ID: 2072096
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protective effect of aripiprazole against glutamate cytotoxicity in dopaminergic neurons of rat mesencephalic cultures.
    Matsuo T; Izumi Y; Kume T; Takada-Takatori Y; Sawada H; Akaike A
    Neurosci Lett; 2010 Sep; 481(2):78-81. PubMed ID: 20600606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FGF-2-mediated protection of cultured mesencephalic dopaminergic neurons against MPTP and MPP+: specificity and impact of culture conditions, non-dopaminergic neurons, and astroglial cells.
    Otto D; Unsicker K
    J Neurosci Res; 1993 Mar; 34(4):382-93. PubMed ID: 8097265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bone morphogenetic protein-2 promotes dissociated effects on the number and differentiation of cultured ventral mesencephalic dopaminergic neurons.
    Reiriz J; Espejo M; Ventura F; Ambrosio S; Alberch J
    J Neurobiol; 1999 Feb; 38(2):161-70. PubMed ID: 10022564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute neurotoxic effects of mancozeb and maneb in mesencephalic neuronal cultures are associated with mitochondrial dysfunction.
    Domico LM; Zeevalk GD; Bernard LP; Cooper KR
    Neurotoxicology; 2006 Sep; 27(5):816-25. PubMed ID: 16889834
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genistein protects dopaminergic neurons by inhibiting microglial activation.
    Wang X; Chen S; Ma G; Ye M; Lu G
    Neuroreport; 2005 Feb; 16(3):267-70. PubMed ID: 15706233
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spatial and temporal growth factor influences on developing midbrain dopaminergic neurons.
    Engele J
    J Neurosci Res; 1998 Aug; 53(4):405-14. PubMed ID: 9710260
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiotensin II increases differentiation of dopaminergic neurons from mesencephalic precursors via angiotensin type 2 receptors.
    Rodriguez-Pallares J; Quiroz CR; Parga JA; Guerra MJ; Labandeira-Garcia JL
    Eur J Neurosci; 2004 Sep; 20(6):1489-98. PubMed ID: 15355316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preferential vulnerability of mesencephalic dopamine neurons to glutamate transporter dysfunction.
    Nafia I; Re DB; Masmejean F; Melon C; Kachidian P; Kerkerian-Le Goff L; Nieoullon A; Had-Aissouni L
    J Neurochem; 2008 Apr; 105(2):484-96. PubMed ID: 18042178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changing responsiveness of developing midbrain dopaminergic neurons for extracellular growth factors.
    Engele J
    J Neurosci Res; 1998 Feb; 51(4):508-16. PubMed ID: 9514204
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Developmental switch in the effects of TNFalpha on ventral midbrain dopaminergic neurons.
    Doherty GH
    Neurosci Res; 2007 Feb; 57(2):296-305. PubMed ID: 17150272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic activation of the cyclic AMP signaling pathway promotes development and long-term survival of mesencephalic dopaminergic neurons.
    Michel PP; Agid Y
    J Neurochem; 1996 Oct; 67(4):1633-42. PubMed ID: 8858948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of alpha-synuclein by bFGF in cultured ventral midbrain dopaminergic neurons.
    Rideout HJ; Dietrich P; Savalle M; Dauer WT; Stefanis L
    J Neurochem; 2003 Feb; 84(4):803-13. PubMed ID: 12562524
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bone morphogenetic proteins: neurotrophic roles for midbrain dopaminergic neurons and implications of astroglial cells.
    Jordan J; Böttner M; Schluesener HJ; Unsicker K; Krieglstein K
    Eur J Neurosci; 1997 Aug; 9(8):1699-709. PubMed ID: 9283824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.